Pharmadrug Inc.

CNSX: BUZZ


Canadian symbol: BUZZ.CN
US symbol: LMLLF

Currency in CAD

Valuation Measures

Market Cap (intraday) 520.54M
Enterprise Value 315.27M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)30.04
Price/Book (mrq)1.85
Enterprise Value/Revenue 322.33
Enterprise Value/EBITDA 7-5.73

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 321.43%
S&P500 52-Week Change 343.61%
52 Week High 30.2050
52 Week Low 30.0200
50-Day Moving Average 30.0930
200-Day Moving Average 30.0859

Share Statistics

Avg Vol (3 month) 33.55M
Avg Vol (10 day) 31.57M
Shares Outstanding 5241.63M
Implied Shares Outstanding 6N/A
Float 193.69M
% Held by Insiders 14.59%
% Held by Institutions 10.00%
Shares Short (Apr. 14, 2021) 4237.53k
Short Ratio (Apr. 14, 2021) 40.16
Short % of Float (Apr. 14, 2021) 4N/A
Short % of Shares Outstanding (Apr. 14, 2021) 40.12%
Shares Short (prior month Mar. 14, 2021) 4250.92k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Aug. 01, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-578.02%

Management Effectiveness

Return on Assets (ttm)-20.52%
Return on Equity (ttm)-73.37%

Income Statement

Revenue (ttm)683.67k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)362.60%
Gross Profit (ttm)182.04k
EBITDA -2.66M
Net Income Avi to Common (ttm)-5.22M
Diluted EPS (ttm)-0.0370
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.4M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)1.13M
Total Debt/Equity (mrq)10.65
Current Ratio (mrq)7.57
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-1.41M
Levered Free Cash Flow (ttm)-1.32M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Psychedelics News and Psilocybin Investing

Real-time news from hundreds of sources. Never miss the news that matters the most.




Company News Date
BUZZ.CN
Pharmadrug
1 week ago
BUZZ.CN
Pharmadrug
3 months ago
BUZZ.CN
Pharmadrug
3 months ago
BUZZ.CN
Pharmadrug
3 months ago
BUZZ.CN
Pharmadrug
5 months ago
BUZZ.CN
Pharmadrug
5 months ago
BUZZ.CN
Pharmadrug
11 months ago
BUZZ.CN
Pharmadrug
11 months ago
BUZZ.CN
Pharmadrug
11 months ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
4.59%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Pharmadrug Inc.


Canada and Délı̨nę Got’ı̨nę Government sign historic Governance Agreement in support of the Great Bear Lake Remediation Project

BOULDER, Colo., Feb. 10, 2021 -- Scaled Agile, Inc., provider of SAFe®, the world's leading framework for business agility, today announced an update to SAFe® 5. The evolving Scaled Agile Framework expands upon the significant advances in strategy, execution, technical and leadership competencies needed for an organization to deliver inno... Read More...

Boardwalk REIT Announces February 2021 Distribution

VANCOUVER, BC, Jan. 12, 2021 - Trading resumes in:Company: Pharmadrug Inc.CSE Symbol: BUZZAll Issues: YesResumption (ET): 9:45 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national s... Read More...

PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, today anno... Read More...

Pharmadrug Provides Corporate Update and Balance Sheet Status

Toronto, Ontario--(Newsfile Corp. - December 15, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to provide an update to the status of its balance sheet following the recent general equity market upswing and the increase in PharmaDrug's volume and share price appreciation.Recent market acti... Read More...

Pharmadrug Shortlists Prime Amsterdam Locations for State-of-the-art Smart Shop Superstore and Expands Scope of E-Commerce Platform with Essential Good

Toronto, Ontario--(Newsfile Corp. - November 30, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") will be launching its new Slim Winkel brand in the next couple of weeks. The Company's wo... Read More...

PharmaDrug Positions for Eurozone Psychedelic Distribution as Germany Begins Psilocybin Depression Study

Toronto, Ontario--(Newsfile Corp. - November 23, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") applauds the recent approval by Germany's Federal Institute of Drugs and Medical Devices (BfArM) of a study examining the Efficacy and Safety of Psilocybin in Treatment-Resistant Depression. This marks the... Read More...

Dillard’s, Inc. Announces $0.15 Cash Dividend

Dillard’s, Inc. (NYSE: DDS) (the "Company" or "Dillard’s") announced that the Board of Directors declared a cash dividend of $0.15 per share on the Class A and Class B Common Stock of the Company payable February 1, 2021 to shareholders of record as of December 31, 2020.View source version on businesswire.com: https://www.businesswire.com... Read More...

Dillard’s, Inc. Reports Third Quarter Results

Dillard’s, Inc. (NYSE: DDS) (the "Company" or "Dillard’s") announced operating results for the 13 and 39 weeks ended October 31, 2020. This release contains certain forward-looking statements. Please refer to the Company’s cautionary statements included below under "Forward-Looking Information." In particular, these results include certai... Read More...

PharmaDrug’s Super Smart Begins to Work with Essential Good to Develop Its Brand and Build an Innovative Online Retail Platform

Toronto, Ontario--(Newsfile Corp. - October 13, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has begun to work with Essential Good LLC ("Essential Good") to develop its Slim Wink... Read More...

PharmaDrug’s Super Smart Reaches Distribution Agreement with Red Light Holland for iMicrodose Packs and for Red Light Holland to Build out an iMicrodose Media Information Centre (iMIC) with Super Smart’s Location in Tiel, The Netherlands

Toronto, Ontario--(Newsfile Corp. - September 28, 2020) -  PharmaDrug Inc. (CSE: BUZZ) (OTC PINK: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has reached a distribution agreement with Red Light Holland Corp. (CSE: TRIP) (FSE... Read More...

PharmaDrug Inc. Closes Transaction to Acquire First Smart Shop in the Netherlands and Now Initiates Major Push to Acquire Best of Breed High Traffic Locations

Toronto, Ontario--(Newsfile Corp. - September 21, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has closed the transaction to acquire the retail establishment specializing in the sale ... Read More...

PharmaDrug Inc. Enters into Definitive Agreement to Acquire First Smart Shop in the Netherlands

Toronto, Ontario--(Newsfile Corp. - August 11, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has entered into a definitive agreement to acquire (the "Acquisition") a retail establ... Read More...

PharmaDrug Inc. Repays Amounts Owing Under Bridge Loan and Advisory Agreement, Completes Previously Announced Debt Restructuring and Provides Financial Update

Toronto, Ontario--(Newsfile Corp. - July 17, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that it has repaid amounts owing by the Company to the lender (inclusive of interest and fees) pursuant to a bridge loan (the "Bridge Loan") and amounts owing to a financial advisor under an ... Read More...

Pharmadrug Inc. Provides Update on Debt Restructuring

Toronto, Ontario--(Newsfile Corp. - July 9, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug") is pleased to announce that further to its press release dated May 20, 2020, that it proposes to complete a restructuring of certain of its outstanding indebtedness.Under the terms of the restructuring the outstanding $400,000 ... Read More...

Pharmadrug Inc. Completes Acquisition of Super Smart with a New Added Focus on the Psychedelic Market

Toronto, Ontario--(Newsfile Corp. - June 15, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") is pleased to announce that it has completed its previously announced (see press release dated May 25, 2020) acquisition of all of the issued and outstanding shares of privately-held Interrobang Ltd. (doing business as Super Smart)... Read More...

Pharmadrug Inc. Enters into Unsecured Promissory Note

Toronto, Ontario--(Newsfile Corp. - May 25, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") announced today that it has issued a non-interest bearing unsecured promissory note to privately-held Interrobang Ltd. (doing business as Super Smart) ("Super Smart") pursuant to which Super Smart will loan the Company $80,000 payab... Read More...

Pharmadrug Inc. Enters Definitive Agreement to Acquire Super Smart Paving Its Entry into the Psychedelic Market

Toronto, Ontario--(Newsfile Corp. - May 25, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") is pleased to announce that it has entered into a definitive agreement (the "Acquisition Agreement") pursuant to which Pharmadrug will acquire all of the issued and outstanding shares of privately-held Interrobang Ltd. (doing busine... Read More...

Pharmadrug Inc. Plans to Enter the Psychedelic Space with An LOI To Acquire Super Smart and Provides Business Update

Toronto, Ontario--(Newsfile Corp. - May 20, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") is pleased to announce that it has entered into a non-binding letter of intent (the "Letter of Intent") dated May 20, 2020 with Interrobang Ltd. doing business as Super Smart (herein referred to as "Super Smart") which outlines the ... Read More...

Pharmadrug Inc. Provides Update on COVID-19 and Announces Request for Extension of Filing Financial Statements as Well as Positive Business and Corporate Updates

Toronto, Ontario--(Newsfile Corp. - April 24, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company") is providing an update on COVID-19 matters and an update on the status of filing its financial statements and accompanying management's discussion and analysis, and related CEO and CFO certifications for the financial year ended ... Read More...

Pharmadrug Announces Q3 2019 Financial Results

Toronto, Ontario--(Newsfile Corp. - November 29, 2019) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "Pharmadrug"), a leading European medical cannabis distribution company, today announced its financial results for the third quarter ending September 30, 2019. The Company's full Management's Discussion and Analysis ("MD&... Read More...

Israeli Government in Discussions on Medical Cannabis Export Framework & Appointment of New Board Member

Toronto, Ontario--(Newsfile Corp. - November 19, 2019) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "Pharmadrug") would like to update investors on developments from Israel's Ministry of Health regarding the export law on medical cannabis passed in January of 2019 (the "Export Law"). It was revealed late last week that the... Read More...

Pharmadrug Signs Major Canadian Supply Agreement with Canada House Wellness for German Distribution as German Governing Party Moves Closer to Recreational Cannabis Legislation

Toronto, Ontario--(Newsfile Corp. - October 31, 2019) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "Pharmadrug") is pleased to announce a multi-year supply agreement (the "Supply Agreement") between 80% owned subsidiary Pharmadrug Production GmbH and Canada House Wellness Group Inc. (CSE: CHV) (the "Grower" or "Canada Hous... Read More...

Aura’s Pharmadrug Signs Major Supply Agreement Setting Stage for Brand Launch & Expanded Distribution

Toronto, Ontario--(Newsfile Corp. - September 19, 2019) - Aura Health Inc. (CSE:BUZZ) (OTC:LMLLF) (the "Company" or "Aura") is pleased to announce a multi-year supply agreement (the "Supply Agreement") between 80% owned subsidiary Pharmadrug Production GmbH ("Pharmadrug") and Israel-based My Green Fields Ltd. ("My Green Fields" or the "Gr... Read More...

Aura Signs Master Grower for Israel

TORONTO, June 14, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce the signing of master grower, Adrian Richelmi, to build and operate HolyCanna’s 60,000 square foot greenhouse facilty in Israel. Aura is a debt holder of HolyCanna that converts into 54% equity (see press release dated November 23, 2018)... Read More...

Aura Provides Clarification on Pharmadrug’s Supply Agreements and Relationship With Bedrocan

TORONTO, June 07, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) wishes to clarify the nature of the supply arrangement by which Pharmadrug Production GmbH (“Pharmadrug”) is importing and distributing cannabis to pharmacies in Germany.In a press release dated June 5th, 2019, the Company announced that Pharmadrug has ordered... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
BUZZ.CD
Canadian Securities Exchange - CSE Listed
Canadian Securities Exchange - CSE Listed0.08CAD-5.88%
BUZZ.CCP
Canadian Composite Quote/Trade
Canadian Composite Quote/Trade0.09CAD+6.25%
LMLLF.PK
US 'Other OTC' and Grey Market
US 'Other OTC' and Grey Market0.07USD-10.47%
LMLLF.PQ
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L20.07USD+5.26%
BUZZ.CXC
Nasdaq CXC
Nasdaq CXC0.09CAD-5.56%
BUZZ.OMG
Tradelogiq Omega ATS
Tradelogiq Omega ATS0.09CAD-5.56%
BUZZ.CXX
Nasdaq CX2
Nasdaq CX20.08CAD-5.88%

Delayed data (1h)


Share this page